NCT00236717View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy

PHASE3CompletedINTERVENTIONAL

Enrollment

865

Participants

Timeline

Start Date

September 30, 1997

Study Completion Date

November 30, 2000

Conditions

EpilepsySeizures

Interventions

DRUG

Topiramate; Carbamazepine; Valproate

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00236717 - A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy | Biotech Hunter | Biotech Hunter